CXCL12 and neoplasm: As anti-SDF-1 treatment counteracts this increased tumor outgrowth by inhibition of neovascularization, the SDF-1/CXCR4 pathway seems to be crucial for tumor angiogenesis mediated by HCs and EPCs.